• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EPHA2在细胞核中与DNA-PK相互作用并调控非小细胞肺癌细胞的电离辐射反应。

EPHA2 Interacts with DNA-PK in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells.

作者信息

Kaminskyy Vitaliy O, Hååg Petra, Novak Metka, Végvári Ákos, Arapi Vasiliki, Lewensohn Rolf, Viktorsson Kristina

机构信息

Department of Oncology/Pathology, Karolinska Institutet, SE-17177 Stockholm, Sweden.

Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, 1000 Ljubljana, Slovenia.

出版信息

Cancers (Basel). 2021 Feb 28;13(5):1010. doi: 10.3390/cancers13051010.

DOI:10.3390/cancers13051010
PMID:33671073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7957683/
Abstract

Ephrin (EFN)/ Erythropoietin-producing human hepatocellular ) signaling has earlier been reported to regulate non-small cell lung cancer (NSCLC) cell survival and cell death as well as invasion and migration. Here, the role of Ephrin type-A receptor 2 (EphA2) on the DNA damage response (DDR) signaling and ionizing radiation (IR) cellular effect was studied in NSCLC cells. Silencing of EphA2 resulted in IR sensitization, with increased activation of caspase-3, PARP-1 cleavage and reduced clonogenic survival. Profiling of EphA2 expression in a NSCLC cell line panel showed a correlation to an IR refractory phenotype. EphA2 was found to be transiently and rapidly phosphorylated at Ser897 in response to IR, which was paralleled with the activation of ribosomal protein S6 kinase (RSK). Using cell fractionation, a transient increase in both total and pSer897 EphA2 in the nuclear fraction in response to IR was revealed. By immunoprecipitation and LC-MS/MS analysis of EphA2 complexes, nuclear localized EphA2 was found in a complex with DNA-PK. Such complex formation rapidly increased after IR but returned back to basal level within an hour. Targeting EphA2 with siRNA or by treatment with EFNA1 ligand partly reduced phosphorylation of DNA-PK at S2056 at early time points after IR. Thus, we report that EphA2 interacts with DNA-PK in the cell nucleus suggesting a novel mechanism involving the EphA2 receptor in DDR signaling and IR responsiveness.

摘要

此前有报道称,Ephrin(EFN)/促红细胞生成素产生性人肝细胞(Erythropoietin-producing human hepatocellular)信号传导可调节非小细胞肺癌(NSCLC)细胞的存活、死亡以及侵袭和迁移。在此,研究了Ephrin A型受体2(EphA2)在NSCLC细胞中对DNA损伤反应(DDR)信号传导和电离辐射(IR)细胞效应的作用。EphA2沉默导致IR致敏,伴有caspase-3激活增加、PARP-1裂解以及克隆形成存活率降低。在一组NSCLC细胞系中对EphA2表达进行分析,结果显示其与IR难治性表型相关。研究发现,EphA2在Ser897位点会因IR而发生瞬时快速磷酸化,这与核糖体蛋白S6激酶(RSK)的激活同时出现。通过细胞分级分离发现,IR可使核组分中总EphA2和pSer897 EphA2均出现瞬时增加。通过免疫沉淀和EphA2复合物的液相色谱-串联质谱(LC-MS/MS)分析,发现核定位的EphA2与DNA依赖性蛋白激酶(DNA-PK)形成复合物。IR后这种复合物的形成迅速增加,但在一小时内恢复到基础水平。在IR后的早期时间点,用小干扰RNA(siRNA)靶向EphA2或用EFNA1配体处理可部分降低DNA-PK在S2056位点的磷酸化。因此,我们报道EphA2在细胞核中与DNA-PK相互作用,提示EphA2受体在DDR信号传导和IR反应性中存在一种新机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/2121be3a7ddc/cancers-13-01010-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/ba95c7bc3f20/cancers-13-01010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/6a82d155c5dd/cancers-13-01010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/3a7e9a107248/cancers-13-01010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/1debea9995df/cancers-13-01010-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/87ad3d9f1791/cancers-13-01010-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/2121be3a7ddc/cancers-13-01010-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/ba95c7bc3f20/cancers-13-01010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/6a82d155c5dd/cancers-13-01010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/3a7e9a107248/cancers-13-01010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/1debea9995df/cancers-13-01010-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/87ad3d9f1791/cancers-13-01010-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a808/7957683/2121be3a7ddc/cancers-13-01010-g006.jpg

相似文献

1
EPHA2 Interacts with DNA-PK in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells.EPHA2在细胞核中与DNA-PK相互作用并调控非小细胞肺癌细胞的电离辐射反应。
Cancers (Basel). 2021 Feb 28;13(5):1010. doi: 10.3390/cancers13051010.
2
Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.Ephrin B3与多种EphA受体相互作用,并驱动非小细胞肺癌的迁移和侵袭。
Oncotarget. 2016 Sep 13;7(37):60332-60347. doi: 10.18632/oncotarget.11219.
3
The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration.EphA2在ADAM17和电离辐射增强肺癌细胞迁移中的作用。
Front Oncol. 2023 Mar 14;13:1117326. doi: 10.3389/fonc.2023.1117326. eCollection 2023.
4
Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.非小细胞肺癌细胞的磷酸蛋白质组学分析表明,Ephrin B3 通过 Akt1 介导的 EphA2 受体磷酸化调节存活信号。
J Proteome Res. 2011 May 6;10(5):2566-78. doi: 10.1021/pr200037u. Epub 2011 Apr 11.
5
EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity.EphA2 在 Ser897 位点的磷酸化由 Cdk1/MEK/ERK/RSK 通路调控,通过维持皮质硬度来调节 M 期进程。
FASEB J. 2019 Apr;33(4):5334-5349. doi: 10.1096/fj.201801519RR. Epub 2019 Jan 22.
6
PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.PI3K-Akt信号通路调节基础状态,但丝裂原活化蛋白激酶(MAP)信号通路在体外调节人肿瘤细胞中辐射诱导的XRCC1表达。
DNA Repair (Amst). 2008 Oct 1;7(10):1746-56. doi: 10.1016/j.dnarep.2008.06.017. Epub 2008 Aug 22.
7
Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity.敲低核仁素表达通过影响DNA依赖蛋白激酶催化亚基(DNA-PKcs)活性增强非小细胞肺癌的放射敏感性。
Asian Pac J Cancer Prev. 2015;16(8):3301-6. doi: 10.7314/apjcp.2015.16.8.3301.
8
DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.DNA-PKcs 缺乏抑制电离辐射后胶质母细胞瘤细胞来源的血管生成。
J Cell Physiol. 2015 May;230(5):1094-103. doi: 10.1002/jcp.24841.
9
Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation.erbB 受体和 DNA-PKcs 在 erbB1 配体和电离辐射诱导的细胞质和核 Akt S473 磷酸化中的作用。
Radiother Oncol. 2011 Oct;101(1):140-6. doi: 10.1016/j.radonc.2011.06.004. Epub 2011 Jun 30.
10
Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.靶向AKT1通过抑制DNA-PKcs依赖的DNA双链断裂修复增强人肿瘤细胞的辐射毒性。
Mol Cancer Ther. 2008 Jul;7(7):1772-81. doi: 10.1158/1535-7163.MCT-07-2200.

引用本文的文献

1
Proteome changes associated with effect of high dose single-fractionation radiation on lung adenocarcinoma cell lines.与高剂量单次分割放疗对肺腺癌细胞系作用相关的蛋白质组变化
Sci Rep. 2025 Jul 7;15(1):24245. doi: 10.1038/s41598-025-09285-4.
2
Development of an anti-human EphA2 monoclonal antibody EaMab-7 for multiple applications.用于多种应用的抗人EphA2单克隆抗体EaMab-7的研发
Biochem Biophys Rep. 2025 Apr 1;42:101998. doi: 10.1016/j.bbrep.2025.101998. eCollection 2025 Jun.
3
Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma.

本文引用的文献

1
The Role of the Eph Receptor Family in Tumorigenesis.Eph受体家族在肿瘤发生中的作用。
Cancers (Basel). 2021 Jan 8;13(2):206. doi: 10.3390/cancers13020206.
2
Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer.EphA2 受体酪氨酸激酶对 PLCγ1 的磷酸化促进肺癌肿瘤生长。
Mol Cancer Res. 2020 Nov;18(11):1735-1743. doi: 10.1158/1541-7786.MCR-20-0075. Epub 2020 Aug 4.
3
Approaches to Manipulate Ephrin-A:EphA Forward Signaling Pathway.操纵 Ephrin-A:EphA 正向信号通路的方法。
患者来源的肿瘤类器官模拟胶质母细胞瘤中治疗诱导的DNA损伤反应。
iScience. 2024 Jul 31;27(9):110604. doi: 10.1016/j.isci.2024.110604. eCollection 2024 Sep 20.
4
Evolutionary dependency of cancer mutations in gene pairs inferred by nonsynonymous-synonymous mutation ratios.通过非同义-同义突变比推断出的基因对中癌症突变的进化依赖性。
Genome Med. 2024 Aug 19;16(1):103. doi: 10.1186/s13073-024-01376-7.
5
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer.靶向 EphA2:克服癌症化疗耐药和耐药性的有前途策略。
J Mol Med (Berl). 2024 Apr;102(4):479-493. doi: 10.1007/s00109-024-02431-x. Epub 2024 Feb 23.
6
Eph receptors and ephrins in cancer progression.Eph 受体及其配体在癌症进展中的作用。
Nat Rev Cancer. 2024 Jan;24(1):5-27. doi: 10.1038/s41568-023-00634-x. Epub 2023 Nov 23.
7
Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases.联合辐射和 ATR 抑制剂治疗后免疫原性细胞死亡由凋亡半胱天冬酶双重调节。
Front Immunol. 2023 Jun 6;14:1138920. doi: 10.3389/fimmu.2023.1138920. eCollection 2023.
8
Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.综述:非小细胞肺癌放射抵抗的机制和治疗视角。
Front Immunol. 2023 Feb 14;14:1133899. doi: 10.3389/fimmu.2023.1133899. eCollection 2023.
9
May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?EPH/Ephrin 靶向治疗会给肺癌治疗带来变革吗?
Int J Mol Sci. 2022 Dec 21;24(1):93. doi: 10.3390/ijms24010093.
10
Investigation on the incidence and risk factors of lung cancer among Chinese hospital employees.中国医院职工肺癌发病率及危险因素调查。
Thorac Cancer. 2022 Aug;13(15):2210-2222. doi: 10.1111/1759-7714.14549. Epub 2022 Jul 11.
Pharmaceuticals (Basel). 2020 Jun 30;13(7):140. doi: 10.3390/ph13070140.
4
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications.利用Eph/ephrin生物符号学的力量用于诊疗应用。
Pharmaceuticals (Basel). 2020 Jun 1;13(6):112. doi: 10.3390/ph13060112.
5
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.肿瘤 VEGFR2 的抑制诱导非小细胞肺癌中丝氨酸 897 依赖的 EphA2 肿瘤细胞侵袭和转移。
Cell Rep. 2020 Apr 28;31(4):107568. doi: 10.1016/j.celrep.2020.107568.
6
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer.适应性RSK-EphA2-GPRC5A信号转导开关触发卵巢癌的化疗耐药性。
EMBO Mol Med. 2020 Apr 7;12(4):e11177. doi: 10.15252/emmm.201911177. Epub 2020 Mar 2.
7
Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors.RSK-EphA2与Gas6-Axl受体酪氨酸激酶信号在精氨酸饥饿应答中的协作赋予对表皮生长因子受体抑制剂的抗性
Transl Oncol. 2020 Feb;13(2):355-364. doi: 10.1016/j.tranon.2019.12.003. Epub 2019 Dec 27.
8
Radiosensitivity Differences between Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses.突变型和野生型肺癌细胞的放射敏感性差异在较低剂量时更大。
Int J Mol Sci. 2019 Jul 25;20(15):3635. doi: 10.3390/ijms20153635.
9
EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2-mediated MAPK pathway activation in gastric cancer cells and avatar mice.Epha2 阻断逆转了 EphA2 介导的 MAPK 通路激活诱导的胃癌细胞和 Avatar 小鼠对阿法替尼的获得性耐药。
Int J Cancer. 2019 Nov 1;145(9):2440-2449. doi: 10.1002/ijc.32313. Epub 2019 Apr 17.
10
Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response.靶向 DNA 双链断裂修复途径以提高放射治疗反应。
Genes (Basel). 2019 Jan 4;10(1):25. doi: 10.3390/genes10010025.